Skip to Content

Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in FDA Alerts

Al-Er-G Capsules by MusclMasster: Recall - Contains Banned Substance Ephedra

[Posted 05/25/2017] ISSUE: MusclMasster, LLC is recalling all bottles of Al-Er-G Capsules. During a recent FDA inspection, it was discovered that this product contained Ephedra Herb, an FDA banned ingredient. Dietary supplements containing ephedrine alkaloids pose a risk of serious adverse events, including heart attack, stroke, and death, and that...

Posted today in Medical

Can Tracking Germs in One Hospital Make All Hospitals Safer?

One hospital's germ history may help doctors curb infections in all hospitals, researchers report. Scientists analyzed more than 10,000 samples collected over 12 months from surfaces, air and water in the University of Chicago's new hospital, the Center for Care and Discovery. Samples were also taken from 252 patients. The samples were collected for...

Posted today in Medical

New Drug Approved for All Cancers With Genetic Marker

Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat any cancer that has a certain genetic biomarker, regardless of where in the body the cancer originated. "This is an important first for the cancer community," said Dr. Richard Pazdur, acting director of the agency's Office of Hematology and Oncology Products....

Posted 3 days ago in New Drug Approvals

FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis

The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the first FDA-approved therapy, specific to this type of vasculitis. “We expedited the development and review of this application because this drug fulfills a critical...

Posted 2 days ago in New Drug Approvals

Sanofi and Regeneron Announce FDA Approval of Kevzara (sarilumab) for Rheumatoid Arthritis

Sanofi and Regeneron Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) approval of Kevzara (sarilumab) for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more disease modifying antirheumatic drugs (DMARDs), such...

Posted 3 days ago in FDA Alerts

Gadolinium-based Contrast Agents for Magnetic Resonance Imaging (MRI): Drug Safety Communication - No Harmful Effects Identified With Brain Retention

ISSUE: An FDA review to date has not identified adverse health effects from gadolinium retained in the brain after the use of gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI). Including: Ablavar (gadofosveset trisodium) Dotarem (gadoterate meglumine) Eovist (gadoxetate disodium) Gadavist (gadobutrol) Magnevist (gadopentetate...

Posted today in Medical

Blood Test for Pancreatic Cancer Shows Early Promise

Scientists say they've developed a new blood test for identifying pancreatic cancer -- a step that might eventually allow earlier diagnosis. Pancreatic cancer is a particularly deadly type of tumor because it's often detected too late for effective treatment. The still-experimental test detects a bundle of proteins churned out by pancreatic tumors. And...

Posted today in Medical

Sleepless Nights Could Pose Heart Risk Dangers

Getting less than six hours of sleep a night may double the odds of dying from heart disease or stroke for people who already have risk factors for heart disease and diabetes, new research suggests. Known as metabolic syndrome, this cluster of risk factors can include high blood pressure, high levels of LDL ("bad") cholesterol, high blood sugar, obesity,...

Posted today in Medical

2 Doses of HPV Shot Enough to Prevent Genital Warts: Study

New research supports the recent U.S. recommendation for two, rather than three, doses of the human papillomavirus (HPV) vaccine to protect against genital warts in preteens and teens. Investigators at Boston University Medical Center found that two HPV vaccine doses are just as effective as three at preventing genital warts. That's in keeping with...

Posted today in Medical

Compound in Pot Eases Severe Form of Epilepsy

A landmark clinical trial has shown that a compound in marijuana can ease life-threatening seizures in children with a rare and devastating form of epilepsy. Cannabidiol -- a non-intoxicating chemical -- reduced seizure frequency by 39 percent in patients with Dravet Syndrome, researchers report. This is the first randomized, controlled trial to show...

Read more news...

Recently added consumer and prescribing information: Kevzara, Tymlos, Rydapt, Alunbrig, Ingrezza, Austedo, Ocrevus, Dupixent, Zejula, Symproic

Posted in Blog

Drugs.com Recognized as ‘Health Information Website Brand of the Year’ in 2017 Harris Poll EquiTrend® Study

The team at Drugs.com is humbled and heartened to have been recognized as the ‘Health Information Website Brand of the Year‘ in the 2017 Harris Poll EquiTrend Study. The annual Harris Poll EquiTrend® Study measures and compares a brand’s health over time and against key competitors. Other categories measured include travel, financial, automotive and entertainment. […]

Posted in Blog

REMS@FDA: An Upgraded Patient Safety Program

REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]

Posted in Blog

Drugs.com the First Major Consumer Health Publisher to Implement Full HTTPS Encryption

Drugs.com is pleased to announce the introduction of full HTTPS encryption for all web site visitors. With this significant and important change, nearly 70 million monthly visitors will have access to critical health and medicine information in a safe, secure and private environment. Why HTTPS Encryption? Almost everything you do on the Internet leaves a digital […]

See more blog posts or follow us on twitter.

Hide